HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALL.

Saved in:
Bibliographic Details
Title: HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALL.
Authors: McNerney KO; Northwestern University Feinberg School of Medicine, United States., Kwon S; Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States., Naik S; St Jude Children's Research Hospital, Memphis, Tennessee, United States., Fabrizio VA; University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States., Llaurador Caraballo G; Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, United States., Sanchez-Pinto LN; Northwestern University Feinberg School of Medicine, United States., Talleur AC; St. Jude Children's Research Hospital, Memphis, Tennessee, United States., Zeng XL; Northwestern University Feinberg School of Medicine, United States., Baggott C; Stanford University School of Medicine, Stanford Cancer Institute, Stanford, California, United States., Vatsayan A; Children's National Hospital, Washington, District of Columbia, United States., Verneris MR; University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States., Prabhu S; Stanford University School of Medicine, Stanford Cancer Institute, Stanford, California, United States., Rossoff J; Northwestern University Feinberg School of Medicine, United States., Pacenta HL; Cook Children's Medical Center, Fort Worth, Texas, United States., Phillips CL; University of Cincinnati, United States., Talano JM; Medical College of Wisconsin, Milwaukee, Illinois, United States., Moskop A; Medical College of Wisconsin, Milwaukee, Wisconsin, United States., Myers GD; St. Jude Children's Research Hospital, Memphis, Tennessee, United States., Karras NA; City of Hope National Medical Center, Duarte, California, United States., Bonifant CL; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States., Qayed M; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, Georgia, United States., Satwani P; Columbia University Medical Center, New York, New York, United States., Winestone LE; University of California San Francisco Benioff Children's Hospitals, San Fransisco, California, United States., Krupski C; University of Cincinnati, United States., Keating AK; Dana-Farber Cancer Institute and Boston Children's Hospital, boston, Massachusetts, United States., Baumeister SHC; Boston Children's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Egeler E; Stanford University School of Medicine, Palo Alto, California, United States., Stieglitz E; UCSF Benioff Children's Hospitals, San Francisco, California, United States., Curran KJ; Memorial Sloan-Kettering Cancer Center, New York, New York, United States., Mackall CL; Parker Institute for Cancer Immunotherapy, United States., John S; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, United States., Laetsch TW; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States., Gardner RA; Seattle Children's Hospital, Seattle, Washington, United States., Schultz LM; Columbia University Medical Center, New York, New York, United States.
Source: Blood advances [Blood Adv] 2026 Jul 17. Date of Electronic Publication: 2026 Jul 17.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2026020511